Using Brain Imaging Measures in Studies of Procognitive Pharmacologic Agents in Schizophrenia: Psychometric and Quality Assurance Considerations

Biological Psychiatry - Netherlands
doi 10.1016/j.biopsych.2011.01.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Using Human Brain Imaging Studies as a Guide Toward Animal Models of Schizophrenia

Neuroscience
Neuroscience
2016English

Brain Volume in First-Episode Schizophrenia: Systematic Review and Meta-Analysis of Magnetic Resonance Imaging Studies

British Journal of Psychiatry
MedicinePsychiatryMental Health
2006English

Spinal Cord Injury and Quality of Life Measures: A Review of Instrument Psychometric Quality

Spinal Cord
MedicineNeurologyRehabilitation
2000English

Mapping Dopamine Function in Primates Using Pharmacologic Magnetic Resonance Imaging

Journal of Neuroscience
Neuroscience
2004English

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics

Journal of Patient-Reported Outcomes
Health Information ManagementHealth Informatics
2017English

Guidelines for Hypertension: Are Quality-Assurance Measures on Target?

Hypertension
Internal Medicine
2004English

Methodological Considerations for Studies of Brain Glycogen

Journal of Neuroscience Research
Molecular NeuroscienceCellular
2019English

Developing Graduate Studies System in Saudi Universities Using Systems Analysis Approach in Light of Quality Assurance and Accreditation Requirements

Journal of Educational & Psychological Sciences
2016English

Dosage Estimation in Mammography for Quality Assurance and Quality Control Using Adult Mammograms

Radiation Science and Technology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy